key: cord-0758465-z3ltpgun
authors: Jain, Swasti; Meena, Rachana; Kumar, Vijay; Kaur, Ranvinder; Tiwari, Umesh
title: Comparison of hematologic abnormalities between hospitalized coronavirus disease 2019 positive and negative patients with correlation to disease severity and outcome
date: 2022-05-04
journal: J Med Virol
DOI: 10.1002/jmv.27793
sha: 91cccfed32873f5d43a98863d09cee90588f2fae
doc_id: 758465
cord_uid: z3ltpgun

Peripheral blood smear (PBS) changes in coronavirus disease 2019 (COVID‐19) are diverse and have been reported in the literature in the form of case series with relatively smaller sample sizes and with a handful of studies showing the association between PBS and clinical severity. This study aims to highlight the numerical and morphological changes in peripheral blood of COVID‐19 patients and to compare the same in intensive care unit (ICU) and non‐ICU settings as well as with disease severity and outcome. The study included 80 COVID‐19 positive (41 ICU and 39 non‐ICU) patients and 32 COVID‐19 negative ICU patients. Complete blood counts (CBCs) and PBS findings were studied and scored by two pathologists blindfolded. Absolute lymphocyte count (ALC) and absolute eosinophil count (AEC) were significantly lower in COVID‐19 positive cases as compared to the COVID‐19 negative group (p = 0.001 and p = 0.001). COVID‐19 positive group showed significant left myeloid shift (p = 0.021), Dohle bodies (p = 0.025) with significant prominence of acquired pseudo–Pelger–Huët anomaly, ring‐shaped neutrophils, monolobate neutrophils, and plasmacytoid lymphocytes as compared to control group (p = 0.000, p = 0.009, p = 0.046, and p = 0.011, respectively). The overall mean white blood cell (WBC) counts were higher in COVID‐19 positive ICU patients as compared to non‐ICU COVID patients with significant shift to left, presence of ring‐shaped neutrophils, monocyte vacuolation, and large granular lymphocytes (p = 0.017, p = 0.007, p = 0.008, and p = 0.004, respectively). Deceased group showed significantly higher WBC count (p = 0.018) with marked neutrophilia (p = 0.024) and toxic granulation (p = 0.01) with prominence of monocyte vacuolization, ring‐shaped neutrophils, large granular lymphocytes, and reactive lymphocytes. Parameters like myeloid left shift, ring‐shaped neutrophils, monocyte vacuolation, and large granular lymphocytes emerged as highly sensitive markers of disease severity. Therefore, serial CBC with comprehensive PBS analysis should be done in every newly diagnosed hospitalized COVID‐19 patient which potentially predicts the course of the disease.

Coronavirus disease 2019 (COVID- 19) pandemic was first identified in Wuhan, Hubei province, China at the end of the year 2019. 1 As of November 15, 2021 , there had been nearly 253 163 330 confirmed cases and 5 098 174 reported deaths globally. 2 It has been observed that the activation of the immune system with subsequent immunemediated inflammatory response plays an important role in the pathogenesis of COVID-19. Laboratory findings, such as leukopenia, lymphopenia, neutrophilia, eosinopenia, and monocytosis, have been reported in the COVID-19 patients. [3] [4] [5] In addition to these numerical changes, some studies have described morphological changes like atypical lymphocytes, cytoplasmic vacuolation, smudge cells, left myeloid shift, and defect in lobation of neutrophils. [6] [7] [8] However, literature on cell morphology is mostly confined to case reports, short discussions, and case series with relatively smaller sample sizes and with only a few studies showing association with disease severity and its course. 8, 9 2 | AIMS OF THE STUDY To study the morphological spectrum of peripheral blood smear (PBS) changes in COVID-19 positive patients and to compare these with COVID-19 negative ICU patients.

To correlate these findings with the clinical severity of the disease and its course.

This study was conducted over a period of 3 months from December 2020 to February 2021. Eighty (80) COVID-19 cases were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) on nasopharyngeal and oropharyngeal swabs sampling and 32 COVID-19 negative ICU patients (which served as controls) were included in this study. The patients with a history of hematologic disorders (including leukemia, lymphoma, myelodysplasia/myeloproliferative neoplasm), autoimmune disorders, chronic use of immunosuppressants, and alcohol were excluded from the study. COVID-19 positive group was composed of 41 intensive care unit (ICU) and 39 non-ICU patients on the basis of disease severity. The control group was comprised of age and sex-matched individuals admitted to ICU settings for conditions like pneumonia, ischemic heart disease, heart failure, renal failure, and sepsis. The patients were followed till 21 days after the admission. The data were collected from the patients' records at the time of diagnosis and included age, gender, relevant clinical and treatment history along with laboratory investigations. The data on disease severity (ICU and non-ICU) and course (survived and deceased) were also collected.

Complete blood count (CBC) with PBS examination was performed in all of these patients at the time of admission to the hospital. The PBS were stained with May Grunwald Giemsa stain (MGG) and were screened by two pathologists who were blinded as to their identity.

The changes in the white blood cell (WBC) morphology were reported as "positive" if they were noted in more than 5% of the cells on PBS. With regard to granulocytes, the variations included the presence of toxic changes (toxic granulation, Dohle bodies, and cytoplasmic vacuolation), smudged neutrophils, apoptotic neutrophils, myeloid left shift, hypersegmentation, monolobation, acquired pseudo-Pelger-Huët anomaly (APHA), and ring-shaped neutrophils (ring-shaped/doughnut-shaped nuclei). Toxic granulation was graded as 1 (scattered granules in the cytoplasm with an increase in the staining intensity), 2 (increased number of granules in the cytoplasm with an increase in stain intensity), 3 (abundance of granules with intense blue-black staining), and 4 (numerous coarse granules crowding the cytoplasm). 10 Shift to left and hypersegmentation were graded on a 4-point scale as 0 (present in <5% of cells), 1 (present in 5%-10% of cells), 2 (present in 11%-25% of cells), and 3 (present in >25% of cells). 7 The variations in lymphocytes included the presence of reactive lymphocytes (including plasmacytoid forms), atypical lymphocytes, large granular lymphocytes (above the normal range), and cytoplasmic vacuolation. The morphological changes for monocytes included the presence of coalescing cytoplasmic vacuoles. The morphologic changes in RBCs and platelets were also noted.

All of the above numerical and morphological parameters were subjected to analysis between COVID-19 positive and COVID-19 negative groups as well as between COVID-19 positive ICU and COVID-19 positive non-ICU groups. Due to limited genomic sequencing, the study of hematologic parameters in different SARS-CoV-2 strains could not be performed.

The data analysis was performed using SPSS v26 software and Microsoft excel. The numerical and morphological data were compared using the Χ 2 test and the p value of ≤0.05 was considered significant.

The age group of the COVID-19 positive ICU patients ranged from 30 to 88 years with a mean age of 61.1 years (male to female ratio 

and cellular morphology between COVID-19 positive and control groups (Table 1) Among the CBC parameters, both groups showed anemia (mean, 10 .73 ± 2.4 vs. 10 .81 ± 2.38 gm%, p = 0.88), mild leucocytosis (mean, 13 .45 ± 0.6 vs. 11.80 ± 0.6 ×10 3 /μl, p = 0.25) neutrophilia (mean, 10 .68 ± 0.9 vs. 9.96 ± 1.0 ×10 3 /μl, p = 0.56) and normal platelet count (mean, 2.14 ± 1.2 vs. 2.39 ± 1.1 lac/μl, p = 0.33) ( Figure 1A Interestingly, ring-shaped neutrophils, monocyte vacuolization, and large granular lymphocytes were more prevalent in patients with ICU settings as compared to non-ICU group (p = 0.007, p = 0.008, and p = 0.004, respectively) 4.3 | Comparison of hematological parameters and cellular morphology between COVID-19 positive ICU survived and deceased patients (Table 3) In COVID-19 positive ICU patients, mortality was high (35.8% [14/ 39]) as compared to non-ICU group where only 3 patients out of 41 (7.3%) died of the disease during the study period.

The WBC count was significantly high in the deceased group However, no significant difference was noted which could be due to the limited sample size.

Coronavirus disease (COVID-19) is an infectious disease with both pulmonary and extra-pulmonary manifestations. 11 Only a handful of published data have shown that COVID-19 also affects blood cells and causes a spectrum of hematological and morphological changes which are distinct in patients depending on the disease severity. [7] [8] [9] 11, 12 The current study showed a significant difference in CBC and peripheral smear morphology between the COVID-19 positive group and the control group as well as in COVID-19 patients in ICU and non-ICU settings.

This study proposes the use of basic and simple routine investigation, that is, CBC with peripheral smear examination in monitoring COVID-19 patients and predicting disease severity and its course thus, ensuring medical interventions at the earliest in hospitalized patients.

In the current study, COVID-19 positive ICU patients were about a decade older than the non-ICU patients which are similar to that reported by Fan et al. 13 where the median age of the ICU patients was 54 years old while that of non-ICU patients was 42 years old confirming that age was an independent risk factor for severity of COVID-19 infection. 13 Clinical presentation with respiratory symptoms and underlying were significantly lower as compared to mild/moderate cases, that is, in non-ICU settings. This was in concordance with the studies which have reported lower monocyte counts and eosinophils counts were associated with disease severity. 13, [17] [18] [19] It has been postulated that due to significant elevation of CXCL10 and CCL2 in critically ill COVID-19 positive patients, there may be the recruitment of monocytes to the sites of inflammation (i.e., lungs) leading to monocytopenia. 16 Higher viral load of SARS-CoV-2 in severe cases causes eosinopenia by depletion of CD8 T cells which contributes to eosinophil proliferation and activation by secreting interleukin-5, and also virus triggered eosinophil granule protein consumption. 18 T A B L E 1 Age and sex distribution, CBC, and morphological parameters in COVID positive (ICU and non-ICU) patients and COVID negative ICU patients. Langenhujsen et al. 26 found neutrophils with ring-shaped nuclei in 12 out of 28 patients with myeloproliferative disease and only rarely in patients with toxemic granulocytosis. 26 Ring-shaped neutrophils in a COVID-19 patient were also observed by Singh et al. 8 Presence of ring-shaped neutrophils can be an important morphological marker of abnormal granulopoiesis indicating progression of disease severity. However, the underlying pathophysiology and mechanism of this process need to be studied. There was also significant prominence of monocyte vacuolization and large granular lymphocytes in severe COVID-19 positive cases as compared to those in non-ICU settings. Zhang et al. 27 described the presence of large, atypical, vacuolated monocytes in circulation which correlated with the disease outcome. 27 LGLs play an important role in the cytotoxic response to specific antigens, especially in viral infections like Epstein-Barr virus (EBV) and cytomegalovirus (CMV). 28 Majority of these cells are derived from natural killer cells and few are cytotoxic T cells subsets. Nazarullah et al. 6 reported LGLs in 11 out of 12 COVID-19 patients. 6 The deceased COVID-19 patients in the current study showed a 

The authors declare no conflicts of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The study was approved by the institutional ethics committee of ABVIMS and RMLH (File number: 478(14/2021)/IEC/ABVIMS/RMLH).

Swasti Jain http://orcid.org/0000-0002-0482-2082

Clinical characteristics of coronavirus disease 2019 in China

World Health Organization. Coronavirus disease (COVID-19) dashboard

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical, laboratory and imaging features of COVID 19: a systematic review and meta-analysis

Morphological anomalies of circulating blood cells in COVID-19

Peripheral blood examination findings in SARS-CoV-2 infection

Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection

Morphology of COVID-19-affected cells in peripheral blood film

Peripheral blood morphologic findings in patients with COVID-19

The correlation between C-reactive protein and toxic granulation of neutrophils in the peripheral blood

The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia

COVID-19): a review of clinical features, diagnosis, and treatment

Hematologic parameters in patients with COVID-19 infection

Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China. Influenza Other Respir Viruses

Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Clinical outcome of eosinophilia in patients with COVID-19: a controlled study

Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study

Hypersegmented granulocytes and COVID-19 infection

Red blood cells injuries and hypersegmented neutrophils in COVID-19 peripheral blood film. medRxiv

Acute respiratory distress syndrome neutrophils have a distinct phenotype and are resistant to phosphoinositide 3-kinase inhibition

Neutrophil subset responses in infants with severe viral respiratory infection

Early hematological indicators of severe COVID-19 disease in hospitalized patients: data from a South Asian population

Leukoerythroblastic reaction in a patient with COVID-19 infection

Neutrophils with ring-shaped nuclei in myeloproliferative disease

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes

Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches

Peripheral blood smear findings of COVID-19 patients provide iṅformation about the severity of the disease and the duration of hospital stay